在帕金森病的发展中,N6-甲基氨酸修饰的潜在作用
Jiale Zhou1, Yang Han1,2, Ruizhe Hou3
1Key Laboratory of Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, China.
Frontiers in cell and developmental biology
|December 29, 2023
概括
N6-甲基氨酸 (m6A) 是一种关键的RNA修饰,影响基因表达. 本综述探讨了它在帕金森病 (PD) 中的作用,并提出了新的治疗途径.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- N6-甲基氨酸 (m6A) 是最常见的mRNA修饰,对RNA代谢至关重要.
- m6A 调控涉及编写器,擦拭器和读取器,影响mRNA稳定性,翻译和衰变.
- m6A在大脑中丰富,与神经发育障碍和帕金森病 (PD) 有关.
研究的目的:
- 审查参与m6A修饰的蛋白质.
- 阐明m6A在帕金森病 (PD) 中的作用.
- 根据m6A.确定PD的潜在治疗策略.
主要方法:
- 关于m6A修饰机制的文献综述.
- 对将m6A与神经发育和PD联系起来的研究分析.
- 对大脑m6A通路的当前知识的综合.
主要成果:
- m6A可以动态调节多个RNA处理步骤.
- 大脑中m6A的丰富表明它在神经元功能中起着关键作用.
- 新出现的证据将m6A失调与PD病变发生联系起来.
结论:
- m6A修饰是RNA生物学中的一个重要因素.
- 了解m6A在PD中的作用提供了新的治疗点.
- 对m6A的进一步研究可能会导致有效的PD预防和治疗策略.
相关概念视频
Parkinson's Disease: Overview
553
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
553
Parkinson's Disease: Treatment
273
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
273
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K


